INS and Insulin resistance: As shown in Table 3, there were no significant differences in fasting blood glucose (FBG), insulin, homeostatic model assessment of insulin resistance (HOMA-IR), homeostatic model assessment of insulin sensitivity (HOMA-S), or homeostatic model assessment of β-cell function (HOMA-B) between NWO and lean, overweight, or obese participants (p > 0.05).